Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Xact Bear XACTBEAR Mar 3, 2021 28.81 -0.28   
 Xact Bear 2 XACTBEAR2 Mar 3, 2021 18.06 -0.45   
 Xact Bull XACTBULL Mar 3, 2021 562.00 +0.27   
 Xact Bull 2 XACTBULL2 Mar 3, 2021 1 166.00 +0.47   
 XACT Högutdelande XACTHDIV Mar 3, 2021 125.18 +0.21   
 Xact OMXS30 XACTOMXS30 Mar 3, 2021 263.55 +0.04   
 XANO Industri B XANOB Mar 3, 2021 154.00 -1.91   
 Xavitech B XAVIB Mar 3, 2021 1.26 +0.80   
 Xbrane Biopharma XBRANE Mar 3, 2021 104.50 +1.95   
 Xintela XINT Mar 3, 2021 2.83 -4.39   
 XMReality XMR Mar 3, 2021 7.78 -2.02   
 Xspray Pharma XSPRAY Mar 3, 2021 118.50 -0.42   
 Xvivo Perfusion XVIVO Mar 3, 2021 323.00 -1.37   
 XXL XXLO Mar 3, 2021 18.90 0.00   
 Yara International YARO Mar 3, 2021 422.40 0.00   
 Zalaris ZALO Mar 3, 2021 54.20 0.00   
 Zaplox ZAPLOX Mar 3, 2021 0.39 -1.02   
 Zenergy B ZENZIPB Mar 3, 2021 0.32 -0.31   
 Zenicor ZENI Mar 3, 2021 13.00 0.00   
 ZetaDisplay ZETA Mar 3, 2021 15.25 -0.65   
 Ziccum AB ZICC Mar 3, 2021 22.00 +0.92   
 ZignSec ZIGN Mar 3, 2021 17.80 +0.57   
 Zinzino B ZZB Mar 3, 2021 75.80 +3.27   
 Zoomability ZOOM Mar 3, 2021 12.10 +0.83   
 Zordix B ZORDIXB Mar 3, 2021 41.80 +1.21   
 Zutec ZUTEC Mar 3, 2021 5.60 -0.89   
 Zwipe ZWIPE Mar 3, 2021 23.05 -3.96   
 ÅF Pöyry B AFB Mar 3, 2021 235.80 -0.08   
 Öresund ORES Mar 3, 2021 130.40 +0.62   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK